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Summary.-Five out of 18 primary explants of human carcinomata obtained at
operation have been grown progressively for a minimum of one month in thymecto-
mized, x-irradiated mice reconstituted with syngeneic bone marrow and subse-
quentlytreated also with anti-thymocyte serum. All the tumours whichproliferated
were of gastrointestinal origin, growing locally but not metastasizing although
direct invasion of the ribs occurred in one case. No implanted breast carcinomata
grew in this system.
THE aim of the present experiments
was to determine whether immune-
deficient mice provided a suitable environ-
ment for the progressive growth of
implanted human carcinomata.
Numerous methods of heterotrans-
plantation have been described and re-
viewed (Chesterman, 1959). Itisgenerally
accepted that cell mediated immunity is
largely responsible for xenograft rejection
and that anti-thymocyte serum (James,
1967) and x-irradiation (Toolan, 1955)
are effective immunosuppressants in this
context. Thymectomy appears to en-
hance the action of anti-thymocyte serum
(ATS) on first generation tumour graft
survival in mice (Jeejeebhoy, 1967; Phil-
lips and Gazet, 1970). Thymectomy com-
bined with irradiation and bone marrow
reconstitution to produce immune de-
prived mice is now a well known immuno-
suppressive regimen. A relatively more
permanent immune impairment is pro-
duced in deprived mice than with ATS
treatment alone, which is specific for
T lymphocyte depletion and dependent
on serum potency and the period of its
administration. In these bone marrow
reconstituted mice, a lymphoid population
ofcells willeventually develop sothat ATS
administration would be an added pre-
caution against the cell mediated response
returning. In order to keep ATS toxicity
to a minimum, low doses of serum were
injected twice weekly until the graft
seemed to have established.
MATERIALS AND METHODS
Male and female adult A2G mice, inbred
for at least 45 generations, were used. The
mice were weaned and separated according to
sex at 3 weeks of age. Female New Zealand
white rabbits weighing between 2-5 and 3-5 kg
were employed for ATS preparation.
Two ml of a thymocyte suspension pre-
pared from the thymuses of 8 A2G mice were
injected intravenously through the ear vein
of each rabbit according to the method of
Levey and Medawar (1966). The above
procedure was repeated 14 days later. On
Days 21 and 23, 40-50 ml of blood were
collected from the ear vein of each sensitized
rabbit. On Day 25 the rabbits were anaes-
thetized with Nembutal and bled out com-
pletely via the abdominal aorta. The serum
was pooled and sterilized through a Swinnex
25 millipore filter unit using 0-22 ,tm filters.
After heating at 56°C for 20 min to destroy
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complement, the serum was stored in 5 ml
aliquots at -20°C. Antiserum was tested
on CBA tailskins grafted onto A2G mice.
0 5 ml of ATS was injected subcutaneously
on Days 2 and 5 after skin grafting. The
survival time of the tailskin graft varied
between 19 and 23 days in mice treated with
ATS compared with 11-13 days in the
untreated mice.
Adult thymectomy and lethal whole body
x-irradiation with 850 rad was directly
followed by intravenous bone marrow supple-
ment, according to a standard method for
producing immune deprived mice (Davies
et al., 1966).
The tumour specimens were all obtained
at operation and implanted subcutaneously
within 2 hours. The specimens, stored
during transit in sterile universal containers,
were washed in sterile isotonic saline at the
laboratory. After taking representative por-
tions for histology, the tumour specimen was
sliced into pieces 4 x 2 x 2 mm, taking care
to cause minimum disruption and tearing
of the tissue. One piece of tumour was
implanted into each deprived mouse ofeither
sex at 0-7 days after irradiation. Under
ether anaesthesia the pieces were placed
subcutaneouslyintheleftaxillaryregionusing
a trocar. It was found that due to the
lowered resistance to infection of the treated
mice, implantation was preferable one week
after irradiation. 0-25 ml of ATS was given
subcutaneouslytwice weeklyuntilthe tumour
appeared to be established and was growing
in the host. This usually occurred after 2
months.
Retransplantation of tumours grown in
the deprived mice was carried out using the
same procedure as for the primary explant.
Tumour bearing mice were all killed at
different times because of varying rates of
tumour growth. If the implants showed no
signs of growth or were rejected, the animals
were killed after 2 months. The following
animals tissues: lungs, liver, spleen, kidney,
tumour were fixed in formal saline, embedded
in paraffin and after sectioning stained with
haematoxylin and eosin or PAS before and
after diastase.
RESULTS
The data are summarized in Table I.
Four colorectal and one gastric mucus
secreting carcinomata developed in the
mice. Their histological features are com-
pared in Table II. With one exception,
mitotic activity seemed to increase in the
transplanted material; further detailed
quantitative kinetic studies are required.
The colonic tumour (No. 4) had 6 mitotic
figures/HPF and involved the local lymph
nodes in the patient. Although this
tumourshowed apparent depressedmitotic
activity on transplantation, it attained a
comparatively large volume (Table I)
and invaded the ribs. First generation
transplanted tumours which were rejected
are shown in Table III.
DISCUSSION
The results indicate that this method
can serve to provide a model for growing
human colorectal carcinoma obtained at
operation. There are many inherent vari-
ables in this extended immunosuppressive
technique which would ultimately affect
the colorectal group; only 4 of the 6
implanted tumours grew. There could be
several reasons for this. First, there may
have been inadequate immunosuppression
in some mice. Second, no antibiotic was
administered post irradiation or special
precautions such as sterile water given in
TABLE I.-Comparison of Xenografts
Longest period
of primary
tumour growth
No. of mice in one mouse
implanted (weeks)
8
5
6
15
7
14
14
16
12
12
Volume of
transplant
at death (mm3)
650
320
770
1090
540
No.
Carcinoma
1
2
3
4
5
29
Site in
patient
Colon
Stomach
Colon
Colon
Rectum
Generations
subsequently
transplanted
4
Unsuccessful
2
2
3
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TABLE III.-Comparative Histology of Rejected Carcinomata
Carcinoma Number of tumours Histological diagnosis
Breast 3 Infiltrating duct carcinoma
Breast 2 Medullary carcinoma
Stomach 2 Moderately differentiated
mucus secreting adenocarcinoma
Stomach 2 Poorly differentiated
adenocarcinoma
Rectum 1 Moderately differentiated
carcinoma
Rectum 1 Poorly differentiated
non-keratinizing
squamous cell carcinoma
Pancreas i Hepatic metastasis of
carcinoma of the pancreas
Thyroid 1 Papillary carciinoma
the diet, so that deaths occurred due to
infections. Third, some pieces of the
tumour implanted may have contained
fewer viable cells than others. A dis-
advantage of using pieces and not cell
suspensions is that the number of tumour
cells may not be comparable in each mouse.
The advantage of pieces is that they
preserve some of the original architecture
of the specimen which would otherwise be
destroyed by dispersing the cells to form a
suspension.
Referring to the overall incidence of
tumour " takes " in the gastrointestinal
group, mucus secretion is not an essential
prerequisite for tumour growth as 2 of the
rejected stomach neoplasia were also
mucus secreting. It is encouraging to
note that Hamilton and Castro (1972);
Franks, Perkins and Thornton Holmes
(1973) and Cobb (1972, private com-
munication) have independently found
colonic tumours easier to grow in deprived
mice. Neither group has used ATS. In
addition to this Povlsen and Rygaard
(1971) have confirmed that it is easier to
xenograft human colonic tumours to the
mutant " nude " mouse.
The metastasis ofsomehumantumours
to the lungs of thymectomized ATS
treated hamsters has been reported (Cobb,
1972) but there was no evidence of
metastatic deposits in lung, liver, kidney
or spleen in the present work.
Breast carcinoma is influenced by
hormones in the human situation but
mouse breast tumours do not metastasize
frequently and generally are not hormone
dependent (MacMahon, Cole and Brown,
1973). Other workers have experienced
poor results when trying to grow human
breast carcinomata. The reasons may be
related to the dense stroma and the rela-
tive paucity of tumour cells, but this does
not explain why other non-schirrous
tumours can also be rejected.
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